3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Active not recruiting
1
Sponsor
Conditions
Tuberous Sclerosis
1
Neoplasms
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Lip Neoplasms
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Endocrine Gland Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
12
Cisplatin
7
Cetuximab
7
Carboplatin
7
Docetaxel
6
Blood Specimen Collection
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
toripalimab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
tocilizumab
1
regorafenib
1
osimertinib
1
lenvatinib
1
fludarabine
1
ficlatuzumab
1
cemiplimab
1
calcipotriene
1
bintrafusp alfa protein, human
1
avelumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
aflibercept
1
Watchful Waiting
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Squamous Cell
×
Phlebotomy
×
Clear all
No trials found.